Science Explorer Back to mapMap
Discussion
Nonprofit · Indianapolis · United States

Indiana Cancer Consortium

In research, Indiana Cancer Consortium stands highest in Health Sciences (#2,798 of 16,688 worldwide) and Medicine (#2,649 of 14,558 worldwide), over all time.

indianacancer.orgROR OpenAlex
World rank, 2022-now
#19,902
of 22,385 · #11,168 all time
Rank in United States
#2,950
of 3,332
Research works
285
▲ 49% vs 2018-21
Citations
9.5k
33.3 per fractional work
Top-10% rate
19.4%
all institutions 10.0%
vs its own fields
1.05×
1.00× is exactly expected
Open access
56%
world 40%
International
20%
world 18%
Indiana Cancer Consortium

What is Indiana Cancer Consortium known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #2,798 of 16,688 16.1%180
MedicineField #2,649 of 14,558 16.1%174

Each strip is that field's whole ranked pool, with the notch where Indiana Cancer Consortium sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Indiana Cancer Consortium work in?

In 2022-now, 62% of research at Indiana Cancer Consortium is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (61%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (5%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 51 fractional works · 62.4% of its workMedicine: 50 fractional works · 60.5% of its workOncology: 16 fractional works · 19.1% of its workPulmonary and Respiratory Medicine: 6 fractional works · 7.4% of its workHematology: 4 fractional works · 5.1% of its workSurgery: 4 fractional works · 5.0% of its workEpidemiology: 3 fractional works · 3.2% of its workNeurology: 2 fractional works · 3.0% of its workGenetics: 2 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.2% of its workPhysiology: 1 fractional works · 1.8% of its workPathology and Forensic Medicine: 1 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.7% of its workRheumatology: 1 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.7% of its workReproductive Medicine: 1 fractional works · 0.7% of its workObstetrics and Gynecology: 1 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.6% of its workHealth Professions: 1 fractional works · 1.6% of its workGeneral Health Professions: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.4% of its workIssues, ethics and legal aspects: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 26 fractional works · 31.2% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 23.8% of its workMolecular Biology: 12 fractional works · 14.6% of its workCancer Research: 3 fractional works · 4.1% of its workCell Biology: 2 fractional works · 2.0% of its workGenetics: 2 fractional works · 1.9% of its workBiotechnology: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 4 fractional works · 5.3% of its workImmunology: 4 fractional works · 4.9% of its workMicrobiology: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 1.3% of its workNeurology: 0 fractional works · 0.5% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workToxicology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysical Sciences: 3 fractional works · 3.7% of its workEngineering: 1 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workBuilding and Construction: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 1 fractional works · 0.8% of its workArtificial Intelligence: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workAstronomy and Astrophysics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.2% of its workNuclear Energy and Engineering: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 2.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.1% of its workEconomics and Econometrics: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 0.9% of its workHealth: 0 fractional works · 0.5% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.6% of its workClinical Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.0% of its workALL ITS WORKIndiana CancerConsortium82fractional works, 2022-now
Life Sciences31%Physical Sciences4%Health Sciences62%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine5060.5%
    2. Health Professions11.6%
    3. Nursing00.4%
    1. Biochemistry, Genetics and Molecular Biology1923.8%
    2. Immunology and Microbiology45.3%
    3. Neuroscience11.3%
    4. Agricultural and Biological Sciences00.5%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Engineering11.2%
    2. Computer Science10.8%
    3. Physics and Astronomy00.6%
    4. Environmental Science00.3%
    5. Chemistry00.3%
    6. Energy00.2%
    7. Materials Science00.1%
    8. Mathematics00.1%
    9. Earth and Planetary Sciences00.0%
    1. Economics, Econometrics and Finance11.1%
    2. Social Sciences10.9%
    3. Psychology00.6%
    4. Business, Management and Accounting00.1%
    5. Decision Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.46× its world share, 20 worksBiochemistry, Geneti…Immunology and Microbiology: 5.24× its world share, 4 worksImmunology and Micro…Neuroscience: 0.83× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.01× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.20× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.22× its world share, 0 worksEnergyEngineering: 0.08× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 0.07× its world share, 0 worksMathematicsPhysics and Astronomy: 0.26× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.60× its world share, 1 worksHealth ProfessionsMedicine: 3.15× its world share, 50 worksMedicineNursing: 0.73× its world share, 0 worksNursingBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.05× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.50× its world share, 1 worksEconomics, Econometr…Psychology: 0.19× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.2×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Immunology and Microbiology5.24×4 works
  2. Biochemistry, Genetics and Molecular Biology4.46×20 works
  3. Medicine3.15×50 works
  4. Pharmacology, Toxicology and Pharmaceutics1.01×0 works
  5. Neuroscience0.83×1 works
  6. Nursing0.73×0 works
  7. Health Professions0.60×1 works
  8. Economics, Econometrics and Finance0.50×1 works
  9. Physics and Astronomy0.26×0 works
  10. Energy0.22×0 works
  11. Chemistry0.20×0 works
  12. Psychology0.19×0 works
  13. Agricultural and Biological Sciences0.10×0 works
  14. Computer Science0.10×1 works
  15. Engineering0.08×1 works
  16. Environmental Science0.07×0 works
  17. Mathematics0.07×0 works
  18. Social Sciences0.07×1 works
  19. Decision Sciences0.05×0 works
  20. Materials Science0.04×0 works
  21. Business, Management and Accounting0.02×0 works
  22. Earth and Planetary Sciences0.01×0 works

Who are the top researchers at Indiana Cancer Consortium?

Ranked on the quality score, Andrew Greenspan, Michael J. Dugan and Luke Paul Akard lead among researchers whose main affiliation is Indiana Cancer Consortium.

  1. 1 Andrew Greenspan United States · #2,215,714 worldwide 945 citations · 21 works
  2. 2 Michael J. Dugan United States · #2,912,696 worldwide 1.2k citations · 54 works
  3. 3 Luke Paul Akard United States · #3,213,763 worldwide 2.1k citations · 106 works
All ranked researchers at Indiana Cancer Consortium

What are the most cited papers from Indiana Cancer Consortium?

The most cited paper from Indiana Cancer Consortium is "Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer" (Kathy D. Miller, Molin Wang, Julie R. Gralow et al., 2007), with 3,085 citations. Next come "Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings" (1,205) and "DESI 2024 VI: cosmological constraints from the measurements of baryon acoustic oscillations" (1,100).

Most cited papers
#PaperReleasedCitations
1 Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine Open access 26 Dec 2007 3,085
2 Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings Lisa Sanderson Cox, Stephen T. Tiffany, Arden G. Christen · Nicotine & Tobacco Research Feb 2001 1,205
3 DESI 2024 VI: cosmological constraints from the measurements of baryon acoustic oscillations Adrian Gutierrez Adame et al. · Journal of Cosmology and Astroparticle Physics Open access201 authors Feb 2025 1,100
4 Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab Frank A. Scappaticci, Jamey R. Skillings, Scott N. Holden et al. · JNCI Journal of the National Cancer Institute Open access 8 Aug 2007 938
5 Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results Alexander M. Lesokhin et al. · Nature Medicine Open access 15 Aug 2023 636
All 60 most cited papers, with filters and sorting

Which keywords describe research at Indiana Cancer Consortium?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Cancer, Targeted Therapy, Tumor Microenvironment, Prognostic Factors, Risk Factors and Breast Cancer.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy9▲ 15×15 topics
  2. Chemotherapy8▲ 14×19 topics
  3. Cancer7▲ 6.0×40 topics
  4. Inflammation5▲ 2.8×35 topics
  5. Risk Factors4▲ 4.9×6 topics
  6. Targeted Therapy4▲ 22×5 topics
  7. Tumor Microenvironment4▲ 10×6 topics
  8. Clinical Trials4▲ 6.8×8 topics
  9. Prognostic Factors4▲ 11×10 topics
  10. Breast Cancer4▲ 17×10 topics
  11. Radiotherapy3▲ 11×7 topics
  12. Cancer Therapy3▲ 7.2×14 topics
  13. Metastasis3▲ 12×12 topics
  14. Cancer Incidence3▲ 28×4 topics
  15. Cancer Immunotherapy3▲ 24×3 topics
  16. Staging System3▲ 60×2 topics
  17. Gene Expression3▲ 5.5×11 topics
  18. Prognosis3▲ 9.6×5 topics
  19. Genetic Mutations2▲ 7.1×9 topics
  20. Minimal Residual Disease2▲ 46×2 topics
  21. Population-Based Study2▲ 46×2 topics
  22. Proteasome Inhibitors2▲ 42×2 topics
  23. Tumor Regression2▲ 26×2 topics
  24. Health Disparities2▲ 11×3 topics
  25. Lymphoma2▲ 17×2 topics
  26. Survival Analysis2▲ 10×6 topics
  27. Breast Cancer Screening2▲ 58×1 topic
  28. Clinical Practice Guidelines2▲ 5.0×10 topics
  29. Global Surveillance2▲ 58×1 topic
  30. Immunity2▲ 6.5×6 topics
  31. Molecular Classification2▲ 18×3 topics
  32. Mortality Rates2▲ 29×2 topics
  33. Diagnosis Criteria2▲ 75×1 topic
  34. Immune Checkpoint Blockade2▲ 23×1 topic
  35. International Myeloma Working Group2▲ 75×1 topic
  36. PD-1 and PD-L12▲ 23×1 topic
  37. CAR T Cells2▲ 33×1 topic
  38. Chimeric Antigen Receptor2▲ 33×1 topic
  39. Cell Death2▲ 9.2×6 topics
  40. Genomic Instability2▲ 20×2 topics

Which research topics does Indiana Cancer Consortium publish most on?

By volume in 2022-now: Global Cancer Incidence and Screening, Cancer Immunotherapy and Biomarkers, Multiple Myeloma Research and Treatments and CAR-T cell therapy research.

Global Cancer Incidence …2Global Cancer Incidence and Screening: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksMultiple Myeloma Researc…2Multiple Myeloma Research and Treatments: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksGlioma Diagnosis and Treatment: 2 fractional worksCancer Genomics and Diagnostics: 1 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksMyasthenia Gravis and Thymoma: 1 fractional worksLung Cancer Research Studies: 1 fractional worksTesticular diseases and …1Testicular diseases and treatments: 1 fractional works
OncologyHematologyGeneticsCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 2 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 2 works
  4. 4 CAR-T cell therapy research Oncology 2 works
  5. 5 Glioma Diagnosis and Treatment Genetics 2 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Myasthenia Gravis and Thymoma Neurology 1 works
  9. 9 Lung Cancer Research Studies Oncology 1 works
  10. 10 Testicular diseases and treatments Surgery 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.5%not open44.5%

World: 40% of research is openly available.

with international co-authors19.9%domestic only80.1%

World: 18% is written across borders.

How has Indiana Cancer Consortium's research output changed?

Output in 2022-2025 was 49% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Indiana Cancer Consortium as a percentage of every work published that year, 0.00022% in 2024.

still counting0.00025%0.00050%0.00075%Indiana Cancer Consortium0.00049% in 20251990200020102020

Fractional works of Indiana Cancer Consortium over all fractional works that year. How the balance of science has shifted.

Other research institutions in Indianapolis

All research institutions in Indianapolis

Share Indiana Cancer Consortium's ranking

Indiana Cancer Consortium on Science Explorer

A card with Indiana Cancer Consortium's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Indiana Cancer Consortium. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.